VentriPoint Diagnostics (TSXV:VPT) EPS (Basic) : C$-0.04 (TTM As of Sep. 2024)

View and export this data going back to 2005. Start your Free Trial

What is VentriPoint Diagnostics EPS (Basic)?

VentriPoint Diagnostics's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was C$-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was C$-0.04.

VentriPoint Diagnostics's EPS (Diluted) for the three months ended in Sep. 2024 was C$-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was C$-0.04.

VentriPoint Diagnostics's EPS without NRI for the three months ended in Sep. 2024 was C$-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

VentriPoint Diagnostics EPS (Basic) Historical Data

The historical data trend for VentriPoint Diagnostics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics EPS (Basic) Chart

VentriPoint Diagnostics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.05

-0.02

-0.03

VentriPoint Diagnostics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-0.01	-0.01

VentriPoint Diagnostics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

VentriPoint Diagnostics's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-4.872	-	0)	/	156.824
	=	-0.03

VentriPoint Diagnostics's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.251	-	0)	/	157.479
	=	-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.04

VentriPoint Diagnostics (TSXV:VPT) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

VentriPoint Diagnostics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

VentriPoint Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (TSXV:VPT) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

VPTDF:USA 5V7:Germany

Address

18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4

Website

https://www.ventripoint.com

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

Executives

Victor Johan Hugo	Senior Officer
Hugh Macnaught	Director, Senior Officer
Robert Hodgkinson	Director
George Adams	Director, Senior Officer

VentriPoint Diagnostics Headlines

No Headlines